EUVIMEDEUVIMED entdecken
Crossref

Screening for Biliary Dysplasia Using Brush Cytology in PSC : Prevalence, Risk Factors and Outcomes

Martti Färkkilä iD, Sonja Boyd iD, Fredrik Åberg iD, Andrea Tenca iD, Kalle Jokelainen, Hannu Kautiainen, Johanna Arola

Liver International · 2026-11 · 46 (11)

DOI: 10.1111/liv.70910 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Liver International, online erschienen am 26.10.2026. Verfasst von Martti Färkkilä und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Gastroenterology, Helsinki University Hospital, Abdominal Centre, Helsinki, Finland. Hauptthemen laut MEDLINE: Cholangitis, Sclerosing, Bile Duct Neoplasms, Cholangiocarcinoma, Cytodiagnosis. Die Arbeit nennt 37 Literaturangaben. Gefördert von: Helsingin ja Uudenmaan Sairaanhoitopiiri, The Cancer Foundation Finland.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background and Aims Primary sclerosing cholangitis (PSC) is associated with significantly increased risk of cholangiocarcinoma (CCA) with a 5‐year survival below 10%. Although CCA screening remains controversial, current guidelines recommend annual surveillance via ultrasound or MRI/MRCP. Brush cytology (BC) enables early detection of biliary dysplasia (BD), but its sensitivity varies widely (8%–89%). We assessed the accuracy of BC in detecting CCA, the prevalence and risk factors for BD, and the outcomes of dysplasia screening.

Methods

We analysed 4017 BC samples from 984 PSC patients who underwent ERC. The exclusion criteria ( n = 114) were age at diagnosis < 18 or > 65 years, early CCA diagnosis (< 1 year from PSC diagnosis), and IgG4‐related cholangitis. Demographics, laboratory data and ERC scores were compared between patients with repeated BD findings (≥ 3 times) or CCA (composite endpoint) and those without. Optimal predictors were assessed using time‐weighted AUC and Cox regression.

Results

BD was detected at least once in 10% of the patients. Repeated suspicion of dysplasia in BC was also strongly associated with BD in explanted livers. The negative predictive value was 0.99, and the overall accuracy was 0.91. Only the ERC score (≥ 7, AUC 0.87) and S‐IgG4‐twAUC (≥ 1.06, AUC 0.76) predicted the composite endpoint. Combining both improved accuracy (ERC‐IgG4‐score, AUC 0.88).

Conclusions

Brush cytology has a high negative predictive value for excluding CCA development. The ERC score and S‐IgG4 are key predictors of biliary dysplasia, supporting their use in PSC surveillance. The ERC‐IgG4‐score may help guide individualized monitoring strategies.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Cholangitis, SclerosingBile Duct NeoplasmsCholangiocarcinomaCytodiagnosisHumansFemaleRisk FactorsMalePrevalenceMiddle AgedAdultAgedProportional Hazards ModelsRetrospective Studies

Stichwörter der Autor:innen

ERCbiliary dysplasiabrush cytologycholangiocarcinomasurveillance

Autor:innen und Institutionen

  • Department of Gastroenterology, Helsinki University Hospital, Abdominal Centre, Helsinki, Finland.
  • Helsinki University, Helsinki, Finland.
  • Department of Pathology, Helsinki University Hospital, University of Helsinki, Helsinki, Finland.
  • Transplantation and Liver Surgery Unit, Helsinki University Hospital and University of Helsinki, Helsinki, Finland.
  • Folkhälsan Research Centre, Helsinki, Finland.
  • Institute of Public Health and Clinical Nutrition, University of Eastern Finland, Kuopio, Finland.

ORCID-Profile: Martti Färkkilä, Sonja Boyd, Fredrik Åberg, Andrea Tenca

Förderung

  • Helsingin ja Uudenmaan Sairaanhoitopiiri
  • The Cancer Foundation Finland

Zitieren

APA

Färkkilä, M., Boyd, S., Åberg, F., Tenca, A., Jokelainen, K., Kautiainen, H., & Arola, J. (2026). Screening for Biliary Dysplasia Using Brush Cytology in PSC : Prevalence, Risk Factors and Outcomes. Liver International, 46(11). https://doi.org/10.1111/liv.70910

Vancouver

Färkkilä M, Boyd S, Åberg F, Tenca A, Jokelainen K, Kautiainen H, et al. Screening for Biliary Dysplasia Using Brush Cytology in PSC : Prevalence, Risk Factors and Outcomes. Liver International. 2026;46(11). doi:10.1111/liv.70910

BibTeX
@article{Frkkil2026,
  author = {Färkkilä, Martti and Boyd, Sonja and Åberg, Fredrik and Tenca, Andrea and Jokelainen, Kalle and Kautiainen, Hannu and Arola, Johanna},
  title = {Screening for Biliary Dysplasia Using Brush Cytology in PSC : Prevalence, Risk Factors and Outcomes},
  journal = {Liver International},
  year = {2026},
  volume = {46},
  number = {11},
  doi = {10.1111/liv.70910}
}
Kostenlos starten →